UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Alimentary pharmacology & therapeutics, 2010-10, Vol.32 (8), p.984-989

2010

Volltextzugriff (PDF)

Evidence of poor vitamin status in coeliac patients on a gluten‐free diet for 10 years

Alimentary pharmacology & therapeutics, 2002-07, Vol.16 (7), p.1333-1339

2002

Volltextzugriff (PDF)

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

Scandinavian journal of gastroenterology, 2009, Vol.44 (7), p.838-845

2009

Volltextzugriff (PDF)

Quality of Life of Adult Coeliac Patients Treated for 10 Years

Scandinavian journal of gastroenterology, 1998, Vol.33 (9), p.933-938

1998

Volltextzugriff (PDF)

Living with Coeliac Disease: Controlled Study of the Burden of Illness

Scandinavian journal of gastroenterology, 2002, Vol.37 (1), p.39-42

2002

Volltextzugriff (PDF)

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2005, Vol.128 (7), p.1805-1811

2005

Volltextzugriff (PDF)

Atopic manifestations are more common in patients with Crohn disease than in the general population

Scandinavian journal of gastroenterology, 2004-08, Vol.39 (8), p.731-736

2004

Volltextzugriff (PDF)

Familial Occurrence of Microscopic Colitis: a Report on Five Families

Scandinavian journal of gastroenterology, 2001, Vol.36 (9), p.959-962

2001

Volltextzugriff (PDF)

Increasing fecal butyrate in ulcerative colitis patients by diet: Controlled pilot study

Inflammatory bowel diseases, 2003-03, Vol.9 (2), p.116-121

2003

Volltextzugriff (PDF)

Familial Occurrence of Microscopic Colitis: a Report on Five Families

Scandinavian journal of gastroenterology, 2001-09, Vol.36 (9), p.959-962

2001

Volltextzugriff (PDF)

Clinical trial: colectomy after resue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study

Alimentary pharmacology & therapeutics, 2010, Vol.32 (8), p.984

2010

Volltextzugriff (PDF)

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Inflammatory bowel diseases, 2012-02, Vol.18 (2), p.212-218

2012

Volltextzugriff (PDF)

Quality of life of adult coeliac patients treated for 10 years

European journal of gastroenterology & hepatology, 1998-11, Vol.10 (11), p.977

1998

Volltextzugriff (PDF)

Colectomy after rescue therapy for intravenous-steroid resistant acute ulcerative colitis: a 3-year follow-up study of the Swedish-Danish infliximab/placebo trial

Gut, 2008, Vol.57(Suppl 1), p.A79

2008

Volltextzugriff (PDF)

The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease

Therapeutic drug monitoring, 2011-04, Vol.33 (2), p.200-208

2011

Volltextzugriff (PDF)

Outcome of rescue therapy in steroid-resistant ulcerative colitis: a retrospective study comparing cyclosporine and infliximab

Gut, 2008, Vol.57(Suppl II), p.A265

2008

Volltextzugriff (PDF)

Living with coeliac disease

Scandinavian journal of gastroenterology, 2002, Vol.37, p.39

2002

Volltextzugriff (PDF)

Quality of life of adult celiac patients 10 years later

Gastroenterology (New York, N.Y. 1943), 1998-04, Vol.114, p.A377-A377

1998

Volltextzugriff (PDF)

Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels

Scandinavian journal of gastroenterology, 2024, Vol.59 (2), p.150-155

2024

Volltextzugriff (PDF)

P296 Preclinical protein signatures in blood predict Crohn's disease and Ulcerative colitis several years before the diagnosis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i668-i669

2024

Volltextzugriff (PDF)

Preclinical protein signatures in blood predict Crohn's disease and Ulcerative colitis several years before the diagnosis

JOURNAL OF CROHNS & COLITIS, 2024, Vol.18 (Suppl. 1), p.I660

2024

Volltextzugriff (PDF)

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling

Molecular neurodegeneration, 2017-01, Vol.12 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus

Scientific reports, 2019-05, Vol.9 (1), p.7322, Article 7322

2019

Volltextzugriff (PDF)

Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity

Frontiers in molecular neuroscience, 2016-03, Vol.9, p.18-18

2016

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)
Tagungsberichte
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(14)
Medicin
(13)
Medicine
(13)
Female
(12)
Gastroenterology & Hepatology
(12)
Male
(11)
Middle Aged
(11)
Adult
(10)
Medicin Och Hälsovetenskap
(10)
Gastroenterologi
(9)
Biological And Medical Sciences
(8)
Clinical Medicine
(8)
Klinisk Medicin
(8)
Medical And Health Sciences
(8)
Medical Sciences
(8)
Aged
(7)
Gastroenterology And Hepatology
(7)
Gastroenterology. Liver. Pancreas. Abdomen
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Evidence of poor vitamin status in coeliac patients on a gluten‐free diet for 10 years

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

Quality of Life of Adult Coeliac Patients Treated for 10 Years

Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial

Living with Coeliac Disease: Controlled Study of the Burden of Illness

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Atopic manifestations are more common in patients with Crohn disease than in the general population

Familial Occurrence of Microscopic Colitis: a Report on Five Families

Increasing fecal butyrate in ulcerative colitis patients by diet: Controlled pilot study

Familial Occurrence of Microscopic Colitis: a Report on Five Families

Clinical trial: colectomy after resue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Quality of life of adult coeliac patients treated for 10 years

Colectomy after rescue therapy for intravenous-steroid resistant acute ulcerative colitis: a 3-year follow-up study of the Swedish-Danish infliximab/placebo trial

The role of inosine-5'-monophosphate dehydrogenase in thiopurine metabolism in patients with inflammatory bowel disease

Outcome of rescue therapy in steroid-resistant ulcerative colitis: a retrospective study comparing cyclosporine and infliximab

Living with coeliac disease

Quality of life of adult celiac patients 10 years later

Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels

P296 Preclinical protein signatures in blood predict Crohn's disease and Ulcerative colitis several years before the diagnosis

Preclinical protein signatures in blood predict Crohn's disease and Ulcerative colitis several years before the diagnosis

Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling

Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus

Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity

Suchergebnisse filtern